In-vitro studies on mouse oocytes have shown that human follicular fluid and bull testes contain an activity which partially overrides the inhibitory action of hypoxanthine on meiosis. This activity was ascribed to two closely related sterols, subsequently named meiosis-activating sterols (MAS). We have used a potent inhibitor of sterol synthesis, ketoconazole, in order to test in vivo and in vitro whether MAS play a necessary physiological role in the resumption of meiosis in the rat. When administered systemically, ketoconazole (8.3-16.6 mg/rat) suppressed ovulation by 40%. Local unilateral administration of the drug into the ovarian bursa (1.25 mg/bursa) resulted in 75% inhibition of ovulation in comparison with the contralateral ovary. All the ovulated ova in the oviduct were mature. Histological examination of the ketoconazole-treated ovaries revealed mature oocytes trapped in follicles which failed to ovulate. Furthermore, extraction of oocytes from the large follicles of such ovaries revealed that 79% of them were mature. Addition of ketoconazole (0.0001-0.01 mM) to the culture medium did not affect significantly the spontaneous maturation of rat oocytes. However, ketoconazole at a higher concentration (0.1 mM) caused the degeneration of oocytes. Ketoconazole (0.01 mM) did not affect luteinizing hormone (LH)-stimulated oocyte maturation in explanted preovulatory follicles, even though it inhibited follicular progesterone production to levels below the hormone-free control follicles. At higher levels, ketoconazole caused the degeneration of follicles and the enclosed oocytes. In conclusion, using a potent inhibitor of MAS we have failed to confirm the suggested obligatory role of MAS in the resumption of meiosis in the rat both in vivo and in vitro.
Introduction
The meiotic process in antral follicles is normally arrested until stimulated by the preovulatory surge of luteinizing hormone (LH) (Ayalon et al., 1972; . Most, if not all, of the ovulatory actions of LH are initiated by activation of follicular adenylate cyclase and are mediated by cAMP . Nevertheless, the cascade initiated by LH includes activation of additional intracellular signal transduction pathways (Tsafriri and Dekel, 1994) . Resumption of meiosis could be stimulated in preovulatory follicles by a transitory exposure to permeant cAMP analogues, phosphodiesterase inhibitors and forskolin Dekel and Beers, 1978; Hillensjö et al., 1978; Dekel et al., 1981; Dekel and Sherizly, 1983; Yoshimura et al., 1992a,b) . Thus, at present, most of the data available regarding the resumption of meiosis in preovulatory follicles can be related to a temporal increase in follicular and oocyte cAMP levels. The role of cAMP in oocyte maturation has been reviewed in detail (Tsafriri and Dekel, 1994; Wassarman and Albertini, 1994; Downs, 1995) .
The induction of ovulatory changes by LH, including the resumption of meiosis, is exerted through its interaction with receptors in the somatic cells of the follicle . Gap junctional transport of small molecules between the granulosa cell compartment and the oocyte has been suggested and experimentally confirmed by many studies Dekel and Beers, 1978; Gilula et al., 1978) (for reviews see Tsafriri and Dekel, 1994; Wassarman and Albertini, 1994; Downs, 1995) . The transport of cAMP from the somatic compartment to the oocyte seems to be involved in both the maintenance of meiotic arrest, requiring low sustained oocyte cAMP levels and the resumption of meiosis, which is associated with a temporary surge of cAMP (Dekel et al., 1988) .
The culture of mouse isolated oocytes with inhibitors of the spontaneous resumption of meiosis, such as hypoxanthine, suggested the activity of a positive regulator produced by somatic cells and transported to the oocyte (Eppig and Downs, 1987; Downs et al., 1988; Guoliang et al., 1994; Byskov et al., 1997) . Using the same model system, Byskov et al. (1995) , identified meiosis-activating sterols (MAS) in human follicular fluid and bull testicular tissue. These two sterols, trienol (4,4-dimethyl-5α-cholest-8,14,24,-triene-3α-ol) from follicular fluid and dienol (4,4-dimethyl-5α-cholest-8,24,-diene-3β-ol) from bull testes, as well as two closely related synthetic C 29 sterols modestly increased the proportion of maturing mouse oocytes cultured with the inhibitor, hypoxanthine.
A key enzyme in cholesterol biosynthesis is sterol 14α-demethylase (P 450 14DM) which is encoded by the CYP51 gene, a member of the cytochrome P 450 (CYP) gene superfamily involved in sterol synthesis in fungi, plants and animals (Aoyama et al., 1996) . The human and rat P 450 14DM enzymes are 93% identical (Stromstedt et al., 1996) . Trienol is formed by P 450 14DM-dependent demethylation of lanosterol and converted to dienol by a sterol 14-reductase (Aoyama and Yoshida, 1986) . The enzyme P 450 14DM has been recently shown to be stimulated in immature rat ovaries by equine chorionic gonadotrophin (CG), resulting in a 6-fold increase within 48 h. The activity of ovarian and testicular P 450 14DM was inhibited in vitro by ketoconazole (Yoshida et al., 1996 ). Here we have tested the actions of the potent P 450 14DM inhibitor, ketoconazole, on ovulation in vivo and on the resumption of oocyte maturation both in vivo and in vitro using well-characterized rat models. It was assumed that if the described C 29 sterols play an essential and physiological role in the resumption of meiosis, and thus function as MAS, ketoconazole should block or attenuate the spontaneous maturation of isolated oocytes and of follicle-enclosed oocytes stimulated to mature by LH.
Materials and methods

Animals
Rats from the Department of Hormone Research Wistar-derived colony were provided with water and rat chow ad libitum and housed in air-conditioned rooms illuminated for 14 h/day. The experiments were carried out in accordance with the principles and guidelines for the use of laboratory animals and approved by the research animal committee of the Weizmann Institute of Science, Rehovot, Israel. Immature rats were injected with equine CG (10 IU) at 09:00-09:30 on day 25-26 of age in order to enhance multiple follicular development. For testing ovulation in vivo, the animals were stimulated to ovulate by human chorionic gonadotrophin (HCG, 4 IU) 53 h later (afternoon of 'proestrus'). For explanting cumulus-oocyte complexes for culture the animals were killed 48-50 h after equine CG by cervical dislocation. For explantation of follicles, only mature proestrous rats that had shown at least two 4-day cycles, as determined by daily vaginal smears immediately before the start of the experiment, were used.
The ovulatory response in vivo
Two days after equine CG treatment, immature rats were administered with the indicated doses of ketoconazole or vehicle (0.6 ml) i.p. or into their peri-ovarian sac (bursa) at 09:30-10:30. For intrabursal injection the animals were anaesthetized by a cocktail of ketamine (40-60 mg/kg) and diazepam (2-3 mg/kg) and one of the ovaries was exteriorized via a small lumbosacral incision. A 29-gauge needle was threaded into the ovarian bursa via the adjoining fat pad. The location of the injection was confirmed by the observation of the swelling of the bursa. After injection of ketoconazole or vehicle (50 µl/bursa), the ovary was replaced into the abdominal cavity, and the skin was sutured. The contralateral ovary served as control. Our previous studies established that intrabursal injection of saline does not significantly affect the number of ovulated ova (Reich et al., 1983; Tsafriri et al., 1989) .
Culture media and inhibitors
Oocytes and follicles were cultured in Leibovitz's L-15 medium ( L-15; Gibco, Grand Island, NY, USA), supplemented with 5% fetal 484 bovine serum (Sera-Lab, Crawley Down, UK), penicillin (100 IU/ml) and streptomycin (100 µg/ml; Gibco). IBMX (Sigma, St Louis, MO, USA) was kept in stock solution in dimethyl sulphoxide (10 mM) and ketoconazole (gift from Abic, Netanya, Israel) was dissolved in 0.5N HCl, neutralized with 0.5N NaOH and diluted with saline (25 mg/ml; 1/4 v/v). This stock solution was further diluted for culture with the medium. The same vehicle either was injected into control rats or was included in control culture media. The animals were killed the next morning, the ampullae of the oviducts were excised and the ova released, counted under a dissecting microscope, and then transferred for evaluation of their meiotic status under Nomarski interference contrast microscopy. Likewise, the ovaries of ketoconazole-treated rats were collected and the oocytes of the largest follicles were isolated for examination of their maturation.
Oocyte collection and culture
All oocyte manipulations were performed under dissecting microscope. Oocytes were collected into a medium containing IBMX (200 µM) by puncturing the largest ovarian follicles with a 27 gauge needle and exerting gentle pressure. Before transfer to the test medium the oocytes were washed twice in plain medium. Oocytes (n ϭ 25-50), within their attached cumulus cell mass ('isolated oocytes'), were cultured in organ culture dishes (Falcon, Cockeysville, MD, USA) for 6 or 24 h in 1 ml of control or test media, as indicated in the Results section. Oocytes from three rats were pooled and distributed into at least three different treatment dishes. Each treatment was tested in at least two replicate cultures repeated in two separate experiments.
Follicle cultures
Immature Wistar-derived rats treated with equine CG (10 IU) or mature rats, that have shown two consecutive 4-day cycles immediately before the experiment, were killed on the morning of the day of proestrus by cervical dislocation. Preovulatory follicles were excised under a dissection microscope as previously described . The follicles, 5-10 per dish, were cultured for 24 h alone or with LH (5 µg/ml) or in combination of LH and the indicated concentration of ketoconazole.
Examination of oocytes
At the end of the 6 or 24 h incubation, isolated oocytes were collected for microscopic examination. Follicle-enclosed oocytes were released and collected after 24 h of culture by making a small incision in the follicle. Some of the ovulated oocytes from the bursae as well as oocytes retained in unruptured large follicles were examined for their meiotic status by Nomarski interference microscopy (Zeiss, Oberkochen, Germany). Oocytes showing a clear nuclear membrane (germinal vesicle; GV) or only an intact nucleolus were classified as immature. Oocytes that did not show any nuclear structures because they have undergone germinal vesicle breakdown (GVBD) were classified as mature (Tsafriri and Kraicer, 1972) .
Statistical analysis
Analysis of variance (ANOVA) and t-test was performed for the ovulation data. Values of oocyte maturation, SE and statistical significance were calculated according to Ott (1988) . P Ͻ 0.05 was considered to be significant.
Progesterone radioimmunoassay
The accumulation of progesterone in medium from follicular cultures was measured by a previously described radioimmunoassay procedure (Lindner and Bauminger, 1974) . 
Results
Effects of ketoconazole on follicle rupture and ovum maturation in vivo
The administration of ketoconazole s.c. (8.3-16.6 mg/rat) into proestrous equine CG-treated immature rats, 4 h before the stimulation of ovulation by HCG, attenuated ovarian follicle rupture by~40% (P Ͻ 0.05) (Figure 1 ). Local administration of the drug into the periovarian sac (i.b.) (1.25 mg/bursa) resulted in an even more pronounced inhibition of ovulation, 75% in comparison with the untreated contralateral ovary (P Ͻ 0.0001) and 70% when compared with vehicle-administered control ovaries (P Ͻ 0.001) (Figure 2 ). All oviductal oocytes in both, s.c.-and i.b.-administered rats were mature and had expanded cumuli (Figure 3) . Histological examination of i.b.-treated ovaries revealed many large follicles which failed to ovulate and that contained entrapped mature oocytes (Figure 4) . Extraction of oocytes from the large follicles of the ketoconazole-treated ovaries revealed that 79% of them were mature (Figure 3 ) and that the cumuli had expanded. Some of the 21% of oocytes which were not mature (in fact six with GV and three degenerated) may have been released from smaller follicles or inadvertently during the handling of the ovaries.
Ketoconazole and oocyte maturation in vitro
Addition of ketoconazole (0.0001-0.01 mM) to the culture medium did not affect the spontaneous maturation of isolated rat follicles (Table I) , although the highest dose tested (0.1 mM) caused degenerative changes in the oocytes. This detrimental effect of ketoconazole on oocytes was even more pronounced when the culture was extended to 24 h. This resulted in advanced degeneration of the oocytes, many of them showing concentration of coarse granules in the centre and the cortical areas of the oocytes ( Figure 5) . To test the effect of ketoconazole on LH-induced maturation, the drug (0.01-1.0 mM) was added to the medium of follicle-enclosed oocytes. The two higher concentrations caused degeneration of the follicles during the culture with complete destruction of the oocytes, precluding the assessment of their meiotic status. Ketoconazole (0.01 mM) did not affect the resumption of oocyte maturation induced by LH ( Figure 6A ) nor cumulus expansion, although this dose suppressed follicular progesterone production to levels below the untreated control follicles ( Figure 6B ). This agrees with the previously reported ability of 1 µM ketoconazole to inhibit rat ovarian P 450 14DM in vitro (Yoshida et al., 1996) .
Discussion
Ketoconazole, an inhibitor of P 450 14DM, at doses which partially inhibited follicle rupture in intact equine CG-HCG stimulated rats, did not affect the hormone-stimulated resumption of oocyte meiosis. Thus, all ovulated oocytes collected from the oviduct were mature and 79% of the oocytes collected from large follicles which did not rupture were mature. Still, it is possible that some of the immature ovarian oocytes were collected from unresponding follicles or were released inadvertently by handling of the ovaries. Furthermore, ketoconazole, at a concentration which effectively inhibited follicular steroidogenesis (0.01 mM), did not affect appreciably the LH-induced maturation of follicle-enclosed oocytes or the spontaneous maturation of oocytes cultured within their cumulus mass. Higher concentrations of the drug (ജ0.1 mM) caused degeneration of both follicle-enclosed oocytes and oocytes cultured within their cumuli. Collectively, in-vivo and in-vitro experiments failed to demonstrate an inhibitory effect of ketoconazole on spontaneous or gonadotrophin-stimulated resumption of meiosis. In view of the reported function of P 450 14DM in ovarian MAS trienol synthesis and the efficient inhibition of MAS synthesis in rat ovarian homogenates by ketoconazole (1 µM; Yoshida et al., 1996) , we have failed to
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show that the resumption of meiosis in the rat is contingent on undisturbed sterol synthesis. Therefore, a role for MAS as an essential mediator of the gonadotrophic stimulus triggering the resumption of oocyte maturation or the spontaneous maturation of isolated oocytes is doubtful. Female gamete production is subject to several stop/go controls (Tsafriri and Dekel, 1994; Wassarman and Albertini, 1994; Downs, 1995) . The oocyte embarks on the first meiotic division during embryonic development. Using a fetal gonad co-culture assay it was suggested that the ovary produces an inducer of meiosis, initially termed meiosis inducing substance (MIS) and later renamed as meiosis activating substance (MAS), and that the testis produces a meiosis preventing substance (MPS) (Byskov and Saxen, 1976) . Human follicular fluid was shown to exert MAS activity as detected by the fetal testis assay (Westergaard et al., 1984 (Westergaard et al., , 1985 . By stimulating the resumption of meiosis in oocytes cultured in the presence of hypoxanthine by forskolin and dibutyryl cAMP (Guoliang et al., 1994) or follicle stimulating hormone (FSH) (Byskov et al., 1997) evidence for an inducer of resumption of meiosis was presented. This activity was also referred to as MAS and identified as a sterol (Byskov et al., 1995) . Clearly, the initiation of meiosis in fetal gonads and the resumption of the first meiotic prophase by dictyotene oocytes are distinct processes in terms of meiotic stage and the developmental stage of the oocyte. Thus the fetal oocyte is prior to its major growth and synthetic phase and only after completing it do the oocytes gain the competence to resume the meiotic process. As far as we are aware, no compelling evidence has been presented that the two activities (i.e. stimulation to initiate meiosis in fetal gonads and to resume the process in competent oocytes) are exerted by the same signal molecule. While there are ample examples that the same molecule may be regulating different processes at various stages of cellular differentiation, attribution of stimulation of these two biological activities to the same molecule is subject to experimental confirmation.
The addition of ketoconazole to rat LH-stimulated follicles blocked follicular steroidogenesis, as revealed by the suppression of progesterone accumulation, without affecting the resumption of meiosis. Thus, the use of ketoconazole confirms and extends previous studies showing that the inhibition of follicular steroidogenesis does not affect the resumption of meiosis in mammals (Lieberman et al., 1976; Moor and Trounson, 1977) , in contrast to the situation in fish (Nagahama, 1994) and amphibia (Maller, 1990) . In spite of some conflicting results, the bulk of evidence favors the view that steroids play only a marginal modulatory role in mammalian oocyte maturation (see detailed reviews by Tsafriri and Dekel, 1994; Wassarman and Albertini, 1994) . Follicular development in mammals and most other vertebrates differs markedly, and this was suggested to explain why steroids could not serve as the stimulus for the resumption of meiosis in these species (Tsafriri and Dekel, 1994) . Large crops of follicles and oocytes growing simultaneously in most lower vertebrates allows the utilization of follicular steroids as a signal between the somatic and germ cell compartments of the follicle. In contrast, mammalian cyclic ovulations and hierarchical follicular development (which span several reproductive cycles), result in the coexistence of follicles and oocytes at different stages of development and the exposure of oocytes to differing levels of steroids. Such cyclic changes in ovarian steroid levels make the distinction between signal and noise in individual oocytes/ follicles very difficult. The same logic may apply to precursors of cholesterol, the sterols. Furthermore, the finding that equine CG treatment of immature mice resulted in an increase in ovarian MAS sterol levels within 48 h (Yoshida et al., 1996) , a time at which oocyte maturation (GVB) does not yet occur and is waiting for additional stimulus (exposure to endogenous or exogenous LH/HCG stimulation), argues against the function of the sterol as MAS. If it was the physiological MAS, it should have stimulated the resumption of meiosis.
In summary, the use of ketoconazole, a potent inhibitor of P 450 14DM and of MAS synthesis, failed to confirm the suggested obligatory role of MAS in the stimulation of the resumption of oocyte meiosis in vivo or in vitro. The suggested physiological role of MAS in the regulation of oocyte maturation should await confirmation by other approaches. Conversely, the attenuation of follicle rupture by a single injection of ketoconazole confirms and extends the study demonstrating inhibition of ovulation and expression of P 450 scc when the drug is given at an early stage of equine CG-stimulated ovarian follicular development (Gal et al., 1997) . Furthermore, these results confirm the essential role of follicular steroids, most probably progesterone, in follicle rupture (for reviews see Espey and Lipner, 1994; . Thus in rodents, ablation of steroid synthesis inhibits follicle rupture, which is re-established by the administration of progesterone (Lipner and Wendelken, 1971; Snyder et al., 1984) . Likewise, midcycle administration of trilostane, a progesterone synthesis inhibitor, prevents follicle rupture, but not oocyte maturation, in macaques. Only progestin, but not androgen, replacement restored ovulation (Hibbert et al., 1996) . Finally, the antiprogestin RU486 inhibits follicle rupture in rodents and the rabbit (Tsafriri et al., 1987; Loutradis et al., 1991; Iwamasa et al., 1992; Kanayama et al., 1994 Kanayama et al., , 1996 , suggesting a paracrine receptor-mediated role of progesterone in the mediation of gonadotrophin-induced follicle rupture.
